SPONSOR
Incyte Corporation
Total Trials
7
Recruiting
7
Phases
Phase 1, Phase 2
Conditions studied: Myeloproliferative NeoplasmsPregnancy RelatedAtopic DermatitisHidradenitis Suppurativa (HS)Chronic Graft-versus-host-diseaseHematologic MalignanciesSolid Tumors
Incyte Corporation is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Myeloproliferative Neoplasms, Pregnancy Related, Atopic Dermatitis, Hidradenitis Suppurativa (HS).
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Incyte Corporation
How many clinical trials has Incyte Corporation sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Incyte Corporation, of which 7 are actively recruiting participants. These trials cover conditions including Myeloproliferative Neoplasms, Pregnancy Related, Atopic Dermatitis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Incyte Corporation research focus on?
Incyte Corporation clinical trials span Myeloproliferative Neoplasms, Pregnancy Related, Atopic Dermatitis, Hidradenitis Suppurativa (HS), Chronic Graft-versus-host-disease, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Incyte Corporation clinical trial?
To participate in a Incyte Corporation trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Incyte Corporation trials with current recruitment status updated daily.
Clinical Trials by Incyte Corporation
NCT07008118 Phase 1
Recruiting
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Myeloproliferative Neoplasms
NCT06627335
Recruiting
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
Pregnancy Related
NCT07213973 Phase 2
Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
NCT07441694 Phase 1
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Myeloproliferative Neoplasms
NCT07124078 Phase 2
Recruiting
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
Chronic Graft-versus-host-disease
NCT06465433 Phase 2
Recruiting
Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab
Hematologic Malignancies
NCT07195916 Phase 1
Recruiting
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Solid Tumors
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology